{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:57:36Z","timestamp":1772121456374,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0081536"],"award-info":[{"award-number":["NNF23OC0081536"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neuroscience.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:47:21Z","timestamp":1755499641000},"page":"240-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["[3H]T-401 binding to monoacylglycerol lipase (MAGL) in the brains of patients and mice with temporal lobe epilepsy"],"prefix":"10.1016","volume":"584","author":[{"given":"Sanjay S.","family":"Aripaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-1974","authenticated-orcid":false,"given":"Burcu A.","family":"Pazarlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H.","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Gastambide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Bang-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper F.","family":"Bastlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens D.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.08.016_b0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","article-title":"Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids","volume":"68","author":"Alger","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108897","article-title":"The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome","volume":"205","author":"Anderson","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jmb.2009.11.060","article-title":"Structural basis for human monoglyceride lipase inhibition","volume":"396","author":"Bertrand","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0035","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/mol.110.068304","article-title":"Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system","volume":"78","author":"Chanda","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.01.024","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults","volume":"178","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.118.252296","article-title":"Monoacylglycerol lipase inhibition in human and rodent systems supports clinical evaluation of endocannabinoid modulators","volume":"367","author":"Clapper","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1523\/JNEUROSCI.0541-22.2022","article-title":"2-AG-mediated control of GABAergic signaling is impaired in a model of epilepsy","volume":"43","author":"Colangeli","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0060","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0065","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma","volume":"163","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2398\u20132403","key":"10.1016\/j.neuroscience.2025.08.016_b0070","first-page":"e2394","article-title":"In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity","volume":"109","author":"Farrell","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0080","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase - a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0085","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ordonez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0095","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/glia.21061","article-title":"The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation","volume":"58","author":"Gomez","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0105","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1038\/srep07642","article-title":"Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents","volume":"5","author":"Griebel","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","article-title":"Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior","volume":"72","author":"Halassa","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0120","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.8b01576","article-title":"Design, synthesis, and evaluation of (4 R)-1-{3-[2-((18)F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbo nyl)piperazin-1-yl]pyrrolidin-2-one ([(18)F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase","volume":"62","author":"Hattori","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0271678X211058285","article-title":"Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [(18)F]T-401 and PET","volume":"42","author":"Hattori","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0130","article-title":"Identification of \u00ae-[(18)F]YH134 for monoacylglycerol lipase neuroimaging and exploration of its use for central nervous system and peripheral drug development","author":"He","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0150","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1523\/JNEUROSCI.4872-05.2006","article-title":"The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum","volume":"26","author":"Kawamura","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/epi.18182","article-title":"TSPO-PET in pre-surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenecity mapping in drug-resistant focal epilepsy","volume":"66","author":"Kilmer","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0170","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105717","article-title":"Binding of the monoacylglycerol lipase (MAGL) radiotracer [(3)H]T-401 in the rat brain after status epilepticus","volume":"175","author":"Mikkelsen","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","article-title":"Therapeutic potential of monoacylglycerol lipase inhibitors","volume":"92","author":"Mulvihill","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0210","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/jpet.109.158162","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling","volume":"331","author":"Pan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","article-title":"The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines","volume":"22","author":"Panikashvili","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0245","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.eplepsyres.2014.10.001","article-title":"Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy","volume":"108","author":"Rizzo","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnbeh.2020.00052","article-title":"Endocannabinoid system and cannabinoid 1 receptors in patients with pharmacoresistant temporal lobe epilepsy and comorbid mood disorders","volume":"14","author":"Rocha","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2014.06.008","article-title":"Sublime microglia: expanding roles for the guardians of the CNS","volume":"158","author":"Salter","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0270","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0275","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0280","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.celrep.2016.06.083","article-title":"Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the suppression of Epileptic Seizures","volume":"16","author":"Sugaya","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0285","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s00259-021-05671-y","article-title":"First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with (18)F-T-401","volume":"49","author":"Takahata","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.13950","article-title":"Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet","volume":"59","author":"Terrone","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0295","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1523\/JNEUROSCI.5665-10.2011","article-title":"Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus","volume":"31","author":"Uchigashima","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0300","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2015.06.075","article-title":"Metabolic interplay between astrocytes and neurons regulates endocannabinoid action","volume":"12","author":"Viader","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12345","article-title":"A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation","volume":"5","author":"Viader","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2025.08.016_b0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nbd.2015.03.016","article-title":"Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice","volume":"77","author":"von Ruden","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0320","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1523\/JNEUROSCI.2419-04.2004","article-title":"ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase","volume":"24","author":"Walter","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0325","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1128\/MCB.00397-06","article-title":"Forebrain-specific inactivation of Gq\/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation","volume":"26","author":"Wettschureck","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s11011-018-0195-5","article-title":"Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures","volume":"33","author":"Zareie","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0335","doi-asserted-by":"crossref","first-page":"22601","DOI":"10.1074\/jbc.M800524200","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.08.016_b0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-023-02701-4","article-title":"Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflammation"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225008462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225008462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T20:48:02Z","timestamp":1758660482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225008462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S0306452225008462"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.08.016","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.06.24.661388","asserted-by":"object"}]},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[3H]T-401 binding to monoacylglycerol lipase (MAGL) in the brains of patients and mice with temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}